The adipokin visfatin insulin sensitivity, inflammation regulator in patients with hypertension and obesity

dc.contributor.authorAndrieieva, Anastasiia
dc.date.accessioned2012-12-05T08:19:26Z
dc.date.available2012-12-05T08:19:26Z
dc.date.issued2012
dc.description.abstractAdipokines play a significant role in the pathogenesis of a lowgrade inflammation associated with obesity, metabolic syndrome and in chronic inflammatory. Visfatin is a novel adipocytokine identified in 2005. On the other hand, visfatin has been suggested to be a beneficial adipokine with insulinmimicking- sensitizing effects, but regulation of visfatin production and its physiological importance in the conditions of obesity and type 2 diabetes mellitus are still not completely understood.uk_UK
dc.identifier.citationAndreeva A. The adipokin visfatin isulin sensitivity, inflammation regulator in patients with hypertension and obesity / A. Andreeva // 5th International Scientific Interdisciplinary Conference (ISIC) for medical students and young doctors, Kharkiv, April 25–26, 2012 : Abstract book. – Kharkiv, 2012. – P. 49–50.uk_UK
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/2170
dc.language.isoenuk_UK
dc.publisherKharkiv National Medical Universityuk_UK
dc.subjectvisfatinuk_UK
dc.subjectinsulin sensitivityuk_UK
dc.subjectinflammationuk_UK
dc.subjecthypertensionuk_UK
dc.subjectobesityuk_UK
dc.titleThe adipokin visfatin insulin sensitivity, inflammation regulator in patients with hypertension and obesityuk_UK
dc.typeThesisuk_UK

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Андреева ISIC.pdf
Size:
4.75 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
6.52 KB
Format:
Item-specific license agreed upon to submission
Description: